A CEO’s Journey: Coming Home to T1D Exchange
Dave Walton brings a combination of personal insight and professional expertise to his role as CEO of T1D Exchange. As…
Insulin-Producing Therapy Shows Continued Promise for Type 1 Diabetes in Human Trials
In recent years, research has made impressive strides in developing potentially life-changing treatments for people with type 1 diabetes (T1D)….
The Journey to a Potential Islet Cell Replacement Therapy for Type 1 Diabetes
When Doug Melton, Ph.D., began his mission to develop an insulin-producing beta cell from a stem cell, he predicted it…
Type 1 Diabetes Stem Cell Therapy Gets Greenlight for Human Trials
On March 9, 2023, Vertex Pharmaceuticals received FDA clearance to begin human trials with a new stem cell therapy, VX-264….
